Application no. and date | 17824314.3 (espacenet) (Federated) (European Patent Register), 20170706 | Patent/reg. no. and date | DK/EP 3482760, 20211110 | Publication date | 20190515 | Priority no. and date | US 201662359504 P, 20160707 | EP pub. no. and date |
EP 3482760 20190515 | Effective date | | Applicant/owner | Ono Pharmaceutical Co., Ltd., 1-5, Doshomachi 2-chome Chuo-ku
Osaka-shi, Osaka 541-8526, JP | Applicant ref. no. | V160768DK | Inventor | YOSHIDA, Takao, c/o Ono Pharmaceutical Co., Ltd. 1-1 Sakurai 3-chome Shimamoto-cho
Mishima-gun Osaka 618-8585, JP, SHOYAMA, Akiko, c/o Ono Pharmaceutical Co., Ltd. 1-1 Sakurai 3-chome Shimamoto-cho
Mishima-gun Osaka 618-8585, JP, TAKANO, Hirotsugu, c/o Ono Pharmaceutical Co., Ltd. 1-1 Sakurai 3-chome Shimamoto-cho
Mishima-gun Osaka 618-8585, JP | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | Opponent | | IPC Class | A61K 31/353 (2006.01) , A61K 45/06 (2006.01) , A61P 35/00 (2006.01) , A61P 43/00 (2006.01) | Title | KOMBINATION, DER OMFATTER EN EP4-ANTAGONIST OG EN IMMUNCHECKPOINT-HÆMMER | Int. application no. | JP2017024753 | Int. publication no. | WO2018008711 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|